+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Amyotrophic Lateral Sclerosis Treatment Market Research Report by Treatment (Medication and Stem Cell Therapy), by Distribution Channel (Hospital Pharmacies and Retail Pharmacies) - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5305507
  • Report
  • March 2021
  • Region: Global
  • 183 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
1 of 4
The Global Amyotrophic Lateral Sclerosis Treatment Market to Grow USD 819.73 Million by 2025, at a CAGR of 6.70%

FEATURED COMPANIES

  • AB Science SA
  • Corestem, Inc.
  • F. Hoffmann-La Roche Ltd
  • Implicit Bioscience Ltd.
  • Kringle Pharma, Inc.
  • ORPHAZYME A/S
  • MORE
Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Amyotrophic Lateral Sclerosis Treatment Market is expected to grow from USD 592.67 Million in 2020 to USD 819.73 Million by the end of 2025.
2. The Global Amyotrophic Lateral Sclerosis Treatment Market is expected to grow from EUR 519.66 Million in 2020 to EUR 718.75 Million by the end of 2025.
3. The Global Amyotrophic Lateral Sclerosis Treatment Market is expected to grow from GBP 461.98 Million in 2020 to GBP 638.97 Million by the end of 2025.
4. The Global Amyotrophic Lateral Sclerosis Treatment Market is expected to grow from JPY 63,252.90 Million in 2020 to JPY 87,485.96 Million by the end of 2025.
5. The Global Amyotrophic Lateral Sclerosis Treatment Market is expected to grow from AUD 860.63 Million in 2020 to AUD 1,190.35 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Amyotrophic Lateral Sclerosis Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment, the Amyotrophic Lateral Sclerosis Treatment Market is examined across Medication and Stem Cell Therapy.

Based on Distribution Channel, the Amyotrophic Lateral Sclerosis Treatment Market is examined across Hospital Pharmacies and Retail Pharmacies.

Based on Geography, the Amyotrophic Lateral Sclerosis Treatment Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Amyotrophic Lateral Sclerosis Treatment Market including AB Science SA, Aquestive Therapeutics Inc., Ascend Pharmaceuticals LLC, Biogen Inc., Biohaven Pharmaceutical Holding Co Ltd, Corestem, Inc., Cytokinetics, Incorporated, F. Hoffmann-La Roche AG, F. Hoffmann-La Roche Ltd, Genervon Biopharmaceuticals, LLC, GNT Pharma Co Ltd., Implicit Bioscience Ltd., Ionis Pharmaceuticals, Inc., ITF Pharma, Inc., Kringle Pharma, Inc., Orion Corporation, ORPHAZYME A/S, Otsuka Pharmaceutical Co., Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd, Synthetic Biologics, Inc., and Treeway BV.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Amyotrophic Lateral Sclerosis Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Amyotrophic Lateral Sclerosis Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Amyotrophic Lateral Sclerosis Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Amyotrophic Lateral Sclerosis Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Amyotrophic Lateral Sclerosis Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Amyotrophic Lateral Sclerosis Treatment Market?
6. What are the modes and strategic moves considered suitable for entering the Global Amyotrophic Lateral Sclerosis Treatment Market?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AB Science SA
  • Corestem, Inc.
  • F. Hoffmann-La Roche Ltd
  • Implicit Bioscience Ltd.
  • Kringle Pharma, Inc.
  • ORPHAZYME A/S
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Distribution Channel Outlook
3.4. Treatment Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population worldwide
5.1.1.2. Increasing incidence rate and growing awareness about ALS
5.1.1.3. Influence of environment and lifestyle on incidence and progress of ALS
5.1.2. Restraints
5.1.2.1. High cost associated with ALS treatment
5.1.3. Opportunities
5.1.3.1. Increasing R&D in the filed
5.1.3.2. Introduction of novel medicines
5.1.4. Challenges
5.1.4.1. Less awareness in developing countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Amyotrophic Lateral Sclerosis Treatment Market, By Treatment
6.1. Introduction
6.2. Medication
6.3. Stem Cell Therapy

7. Global Amyotrophic Lateral Sclerosis Treatment Market, By Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Retail Pharmacies

8. Americas Amyotrophic Lateral Sclerosis Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand

10. Europe, Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. AB Science SA
12.2. Aquestive Therapeutics Inc.
12.3. Ascend Pharmaceuticals LLC
12.4. Biogen Inc.
12.5. Biohaven Pharmaceutical Holding Co Ltd
12.6. Corestem, Inc.
12.7. Cytokinetics, Incorporated
12.8. F. Hoffmann-La Roche AG
12.9. F. Hoffmann-La Roche Ltd
12.10. Genervon Biopharmaceuticals, LLC
12.11. GNT Pharma Co Ltd.
12.12. Implicit Bioscience Ltd.
12.13. Ionis Pharmaceuticals, Inc.
12.14. ITF Pharma, Inc.
12.15. Kringle Pharma, Inc.
12.16. Orion Corporation
12.17. ORPHAZYME A/S
12.18. Otsuka Pharmaceutical Co., Ltd.
12.19. Sanofi SA
12.20. Sun Pharmaceutical Industries Ltd
12.21. Synthetic Biologics, Inc.
12.22. Treeway BV

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis Treatment Market: Research Process
Figure 2. Global Amyotrophic Lateral Sclerosis Treatment Market: Research Execution
Figure 3. Global Amyotrophic Lateral Sclerosis Treatment Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2020 (USD Million)
Figure 5. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2020 (USD Million)
Figure 6. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2020 (USD Million)
Figure 7. Global Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2025 (USD Million)
Figure 8. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2020 Vs 2025 (%)
Figure 9. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 10. Competitive Strategic Window for Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2025
Figure 11. Global Amyotrophic Lateral Sclerosis Treatment Market: Market Dynamics
Figure 12. Global Amyotrophic Lateral Sclerosis Treatment Market: Porters Five Forces Analysis
Figure 13. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2020 Vs 2025 (%)
Figure 14. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2020 Vs 2025 (USD Million)
Figure 15. Competitive Strategic Window for Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2025
Figure 16. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Medication, 2020 Vs 2025 (USD Million)
Figure 17. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Stem Cell Therapy, 2020 Vs 2025 (USD Million)
Figure 18. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2020 Vs 2025 (%)
Figure 19. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2020 Vs 2025 (USD Million)
Figure 20. Competitive Strategic Window for Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2025
Figure 21. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Hospital Pharmacies, 2020 Vs 2025 (USD Million)
Figure 22. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Retail Pharmacies, 2020 Vs 2025 (USD Million)
Figure 23. Americas Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2020 Vs 2025 (%)
Figure 24. Americas Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 25. Competitive Strategic Window for Americas Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2025
Figure 26. Argentina Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 27. Brazil Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 28. Canada Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 29. Mexico Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 30. United States Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 31. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2020 Vs 2025 (%)
Figure 32. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 33. Competitive Strategic Window for Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2025
Figure 34. Australia Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 35. China Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 36. India Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 37. Indonesia Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 38. Japan Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 39. Malaysia Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 40. Philippines Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. South Korea Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 42. Thailand Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 43. Europe, Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2020 Vs 2025 (%)
Figure 44. Europe, Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 45. Competitive Strategic Window for Europe, Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2025
Figure 46. France Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. Germany Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. Italy Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. Netherlands Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. Qatar Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. Russia Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. South Africa Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. Spain Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 55. United Arab Emirates Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 56. United Kingdom Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD Million)
Figure 57. Global Amyotrophic Lateral Sclerosis Treatment Market: Fpnv Positioning Matrix
Figure 58. Global Amyotrophic Lateral Sclerosis Treatment Market: Market Share Analysis
Figure 59. Global Amyotrophic Lateral Sclerosis Treatment Market: Competitor SWOT Analysis
Figure 60. Competitive Scenario Analysis in Global Amyotrophic Lateral Sclerosis Treatment Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 3. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 4. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 5. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Medication, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 6. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Stem Cell Therapy, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 7. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 8. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Hospital Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 9. Global Amyotrophic Lateral Sclerosis Treatment Market Size, by Retail Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 10. Americas Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 11. Americas Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 12. Americas Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 13. Argentina Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 14. Argentina Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 15. Brazil Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 16. Brazil Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 17. Canada Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 18. Canada Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 19. Mexico Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 20. Mexico Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 21. United States Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 22. United States Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 23. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 24. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 25. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 26. Australia Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 27. Australia Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 28. China Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 29. China Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 30. India Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 31. India Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 32. Indonesia Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 33. Indonesia Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 34. Japan Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 35. Japan Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 36. Malaysia Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 37. Malaysia Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 38. Philippines Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 39. Philippines Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 40. South Korea Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 41. South Korea Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 42. Thailand Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 43. Thailand Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 44. Europe, Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 45. Europe, Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 46. Europe, Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 47. France Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 48. France Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 49. Germany Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 50. Germany Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 51. Italy Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 52. Italy Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 53. Netherlands Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 54. Netherlands Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 55. Qatar Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 56. Qatar Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 57. Russia Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 58. Russia Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 59. Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 60. Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 61. South Africa Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 62. South Africa Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 63. Spain Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 64. Spain Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 65. United Arab Emirates Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 66. United Arab Emirates Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 67. United Kingdom Amyotrophic Lateral Sclerosis Treatment Market Size, by Distribution Channel, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 68. United Kingdom Amyotrophic Lateral Sclerosis Treatment Market Size, by Treatment, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 69. Global Amyotrophic Lateral Sclerosis Treatment Market: Scores
Table 70. Global Amyotrophic Lateral Sclerosis Treatment Market: Business Strategy
Table 71. Global Amyotrophic Lateral Sclerosis Treatment Market: Product Satisfaction
Table 72. Global Amyotrophic Lateral Sclerosis Treatment Market: Ranking
Table 73. Global Amyotrophic Lateral Sclerosis Treatment Market: Merger & Acquisition
Table 74. Global Amyotrophic Lateral Sclerosis Treatment Market: Agreement, Collaboration, & Partnership
Table 75. Global Amyotrophic Lateral Sclerosis Treatment Market: New Product Launch & Enhancement
Table 76. Global Amyotrophic Lateral Sclerosis Treatment Market: Investment & Funding
Table 77. Global Amyotrophic Lateral Sclerosis Treatment Market: Award, Recognition, & Expansion
Table 78. Global Amyotrophic Lateral Sclerosis Treatment Market: License & Pricing
Note: Product cover images may vary from those shown
3 of 4
  • AB Science SA
  • Aquestive Therapeutics Inc.
  • Ascend Pharmaceuticals LLC
  • Biogen Inc.
  • Biohaven Pharmaceutical Holding Co Ltd
  • Corestem, Inc.
  • Cytokinetics, Incorporated
  • F. Hoffmann-La Roche AG
  • F. Hoffmann-La Roche Ltd
  • Genervon Biopharmaceuticals, LLC
  • GNT Pharma Co Ltd.
  • Implicit Bioscience Ltd.
  • Ionis Pharmaceuticals, Inc.
  • ITF Pharma, Inc.
  • Kringle Pharma, Inc.
  • Orion Corporation
  • ORPHAZYME A/S
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd
  • Synthetic Biologics, Inc.
  • Treeway BV
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll